IlluminOss for Pelvic Fractures
This study is looking at how well the IlluminOss pelvic implant works for people with certain types of pelvic fractures. This includes those with cancer that has spread to the pelvis (metastatic cancer) causing pain or a risk of fracture, or those who already have a small fracture. It also includes older patients (65 or older) with pelvic fragility fractures. The IlluminOss implant is already approved by the FDA, and your doctor would have decided you need it as part of your standard care. Researchers will ask you about your pain and how well you can do daily activities to see if the implant helps reduce pain and improve function. The study aims to enroll 100 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information about patients who are already receiving the IlluminOss pelvic implant. It is not a randomized study, and the phase is not specified.
- What's involved
- You will be asked to complete surveys about your outcomes from before your surgery up to two years afterward.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to two years after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures
At a glance
Conditions
NCT04842266
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Massachusetts General Hospital
Boston, Massachusettsstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Survey of patient-reported outcomesPre-operatively through 2 years after surgery
Patients treated with the IlluminOss pelvic implant will be given functional and pain surveys pre-operatively (within 2 weeks before surgery) and post-operatively (at 2 days, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, and 2 years). 100 patients will be included in the study. The surveys include the VAS Pain, the EQ-VAS, the Combined Pain and Ambulatory Function, the PROMIS Pain Inteference, and the PROMIS Physical Function. Additionally, the MSTS survey will be collected for oncologic patients. If needed, the surveys will be mailed to the patient with a pre-stamped and pre-addressed envelope. When mailing patients MSTS surveys, we will include a set of instructions to guide participants through the questions.